Opendata, web and dolomites

EVIDENCE SIGNED

Erythrocytes properties and viability in dependence of flow and extra-cellular environment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EVIDENCE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAT DES SAARLANDES 

Organization address
address: CAMPUS
city: SAARBRUCKEN
postcode: 66123
website: www.uni-saarland.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 3˙993˙480 €
 EC max contribution 3˙993˙480 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAT DES SAARLANDES DE (SAARBRUCKEN) coordinator 505˙576.00
2    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS FR (PARIS) participant 549˙604.00
3    Stichting Sanquin Bloedvoorziening NL (Amsterdam) participant 531˙239.00
4    UNIVERSITY OF BRISTOL UK (BRISTOL) participant 303˙172.00
5    UNIVERSITAT ZURICH CH (ZURICH) participant 281˙276.00
6    ERYTECH PHARMA FR (LYON) participant 274˙802.00
7    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 274˙802.00
8    R&R MECHATRONICS INTERNATIONAL BV NL (ZWAAG) participant 265˙619.00
9    CTC RESEARCH GMBH DE (MUNCHEN) participant 252˙788.00
10    NANION TECHNOLOGIES GMBH DE (MUNCHEN) participant 252˙788.00
11    FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES (BARCELONA) participant 250˙904.00
12    FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA ES (BARCELONA) participant 250˙904.00

Map

 Project objective

After exiting the bone marrow, reticulocytes mature to form red blood cells (RBCs) which are highly adapted cells Red blood cells (RBCs) travel through our circulation during their entire lifetime of in average 120 days. This means they are in constant move and adapt to their surrounding by shape changes, e.g., when in high speed flow or with even more severe volume adaptations, when they squeeze through small capillaries or the slits of the spleen having less than half their own size. While on the move, RBCs have to deal with continuous changes in oxygen tension and pH, have to scavenge reactive oxygen species, and need to balance their responses towards the chemical and mechanical challenges. In contrast, most of the knowledge we gained about RBCs as well as diagnostic methods rely on RBCs in relative stasis, such as flux measurements, conventional patch-clamp, calorimetric assays, density centrifugation, atomic force microscopy, just to name a few. In the most extreme conditions the cells of investigation are even dead like in blood smears, electron microscopy or cyto-spins. Even if cells are on the move like in flow cytometers, they may rest in a drop of liquid. Furthermore, when taken from the circulation, the flow of the RBCs is suddenly terminated and (together with the application of anticoagulants) they experience a completely different environment that is likely to impair their properties. The objective of EVIDENCE is the exploration of the properties and behaviour of RBCs under flow conditions and in vivo to understand pathophysiology and to design novel diagnostic devices. Theoretical models will help to understand these RBC properties and will enable the transfer of the gained knowledge into diagnostic devises in general and into the development of a spleen-on-the-chip in particular. Furthermore we aim to understand the effect of the flow in bioreactors, allowing the efficient production of RBCs in vitro with the goal to produce RBC for transfusion.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVIDENCE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVIDENCE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

NL4XAI (2019)

Interactive Natural Language Technology for Explainable Artificial Intelligence

Read More  

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More